Long-term safety of lamivudine treatment in patients with chronic hepatitis B.
By A. Lok, Ching‐lung Lai, N. Leung, G. Yao, Z. Cui, E. Schiff, J. Dienstag, E. Heathcote, N. Little, Dorothea A Griffiths and 2 more. Gastroenterology, 2003
788 citations recorded by the source corpus.
Subfields: Epidemiology, Hepatology, Pharmacology
View Paper: https://www.semanticscholar.org/paper/4ec740c4e844acbd2a5cc4badb72d05628665296
Citations in the corpus
- Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B. (2008, neutral): “Australia or New Zealand 32 (18) 17 (19) 39 ( 16 ) 20 (16)”